The role of metabolomics in neonatal and pediatric laboratory medicine

Clinica Chimica Acta

Volumn 426, Issue , 2013, Pages 127-138

  Mussap, Michele ^a   Antonucci, Roberto ^b   Noto, Antonio ^c   Fanos, Vassilios ^c,d  

^a UNIVERSITY OF GENOA   (Italy)

^b Hospital Nostra Signora di Bonaria   (Italy)

^c DEPARTMENT OF RADIOLOGY   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Mass spectrometry; Metabolomics; Nutrimetabolomics; Pharmametabolomics; Proton nuclear magnetic resonance spectroscopy; System biology

Indexed keywords

SURFACTANT;

ANALYTIC METHOD; BODY FLUID; CELIAC DISEASE; CHILDHOOD; CRITICAL ILLNESS; CYSTIC FIBROSIS; DELIVERY; DIABETES MELLITUS; GENE EXPRESSION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INBORN ERROR OF METABOLISM; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; METABOLITE; METABOLOMICS; NEUROLOGIC DISEASE; NEWBORN; NUTRIMETABOLOMICS; NUTRITION; OBESITY; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PEDIATRICS; PERINATAL ASPHYXIA; PERSONALIZED MEDICINE; PHARMAMETABOLOMICS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT DISEASE; REVIEW; SMALL FOR DATE INFANT; TWINS;

(1)H NMR; ACUTE KIDNEY DISEASE; ACUTE KIDNEY INJURY; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADMA; ADP; AGA; AKD; AKI; AMP; APPROPRIATE FOR GESTATIONAL AGE; ASYMMETRIC DIMETHYLARGININE; BALF; BMI; BODY MASS INDEX; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY ELECTROPHORESIS; CE; CEREBROSPINAL FLUID; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; CKD; CLD; CSF; DIMS; DIRECT INJECTION MASS SPECTROMETRY; ELBW; END STAGE RENAL DISEASE; ESRD; EXTREME LOW BIRTH WEIGHT; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FTIR; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GC-MS; HIE; HMDB; HOMOVANILLIC ACID SULFATE; HUMAN METABOLOME DATA BASE; HVA-SO(4); HYPOXIC ISCHEMIC ENCEPHALOPATHY; ICU; INTELLIGENCE QUOTIENT; INTENSIVE CARE UNIT; INTRAUTERINE GROWTH RESTRICTED; IQ; IUGR; LBW; LC-MS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LOW BIRTH WEIGHT; MALONDIALDEHYDE; MASS SPECTROMETRY; MDA; METABOLOMICS; METHYLMALONIC ACIDEMIA; MMA; MS; NUTRIMETABOLOMICS; OPLS-DA; ORTHOGONAL PROJECTIONS TO LATENT STRUCTURES FOR DISCRIMINANT ANALYSIS; PA; PATENT DUCTUS ARTERIOSUS (BOTALLO'S DUCT); PCA; PDA; PHARMAMETABOLOMICS; PLS-DA; PRINCIPAL COMPONENT ANALYSIS; PROJECTION TO LATENT STRUCTURES DISCRIMINANT ANALYSIS; PROPIONIC ACIDEMIA; PROTON NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RCDS; RDS; RESPIRATORY CHAIN DEFICIENCIES; RESPIRATORY DISTRESS SYNDROME (HYALINE MEMBRANE DISEASE); SGA; SMALL FOR GESTATIONAL AGE; SYSTEM BIOLOGY; TMAO; TRIMETHYLAMINE-N-OXIDE; VERY LOW BIRTH WEIGHT; VLBW; VOCS; VOLATILE ORGANIC COMPOUNDS;

CHILD; HUMANS; INFANT, NEWBORN; MEDICAL LABORATORY SCIENCE; METABOLOME; METABOLOMICS;

EID: 84884958498     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.08.020     Document Type: Review

References (116)

1. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921.
2. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genoma. Science 2001, 291(5507):1304-1351.
3. Mussap M., Fanos V. Reducing neonatal mortality and expenditure in the era of health care crisis: is it possible?. J Matern Fetal Neonatal Med 2012, 25(Suppl. 5):1-3.
4. Williams R.J. Introduction, general discussion and tentative conclusions. University Texas publication no. 5109. Biochemical Institute studies IV. Individual metabolic patterns and human disease: an exploratory study utilizing predominantly paper chromatographic methods 1951, 7-21. The University of Texas, Austin.
5. Horning E.C., Horning M.G. Human metabolic profiles obtained by GC and GC/MS. J Chromatogr Sci 1971, 9:129-140.
6. Pauling L., Robinson A.B., Teranishi R., Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 1971, 68:2374-2376.
7. Gates S.C., Sweeley C.C. Quantitative metabolic profiling based on gas chromatography. Clin Chem 1978, 24:1663-1673.
8. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
9. Fiehn O. Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 2002, 48:155-171.
10. Oliver S.G., Winson M.K., Kell D.B., Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol 1998, 16:373-378.
11. Wishart D.S., Tzur D., Knox C., et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007, 35:D521-D526. [Database issue].
12. Xu E.Y., Schaefer W.H., Xu Q. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Curr Opin Drug Discov Devel 2009, 12:40-52.
13. Schnackenberg L.K. Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century. Expert Rev Mol Diagn 2007, 7:247-259.
14. Oldiges M., Lütz S., Pflug S., Schroer K., Stein N., Wiendahl C. Metabolomics: current state and evolving methodologies and tools. Appl Microbiol Biotechnol 2007, 76:495-511.
15. Griffiths W.J., Wang Y. Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem Soc Rev 2009, 38:1882-1896.
16. Wishart D.S., Knox C., Guo A.C., et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009, 37:D603-D610. [Database issue].
17. Roessner U., Beckles D.M. Metabolite measurements. Plant metabolic networks 2009, 39-69. Springer, New York. J. Schwender (Ed.).
18. Brown M., Wedge D.C., Goodacre R., et al. Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics 2011, 27:1108-1112.
19. 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification. Anal Chem 2010, 82:1811-1821.
20. Pan Z., Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 2007, 387:525-527.
21. Ellis D.I., Goodacre R. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. Analyst 2006, 131:875-885.
22. Krafft C., Steiner G., Beleites C., Salzer R. Disease recognition by infrared and Raman spectroscopy. J Biophotonics 2009, 2:13-28.
23. Brown M., Dunn W.B., Ellis D.I., et al. A metabolome pipeline: from concept to data to knowledge. Metabolomics 2005, 1:39-51.
24. Rifai N., Gillette M.A., Carr S.A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006, 24:971-983.
25. Gika H.G., Theodoridis G.A., Wilson I.D. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies. J Chromatogr A 2008, 1189:314-322.
26. Dunn W.B., Broadhurst D., Begley P., et al. Human Serum Metabolome [HUSERMET] Consortium. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011, 6:1060-1083.
27. Michopoulos F., Theodoridis G., Smith C.J., Wilson I.D. Metabolite profiles from dried biofluid spots for metabonomic studies using UPLC combined with oaToF-MS. J Proteome Res 2010, 9:3328-3334.
28. Kong S.T., Lin H.S., Ching J., Ho P.C. Evaluation of dried blood spots as sample matrix for gas chromatography/mass spectrometry based metabolomic profiling. Anal Chem 2011, 83:4314-4318.
29. Michopoulos F., Theodoridis G., Smith C.J., Wilson I.D. Metabolite profiles from dried blood spots for metabonomic studies using UPLC combined with orthogonal acceleration ToF-MS: effects of different papers and sample storage stability. Bioanalysis 2011, 3:2757-2767.
30. Wilson I. Global metabolic profiling [metabonomics/metabolomics] using dried blood spots: advantages and pitfalls. Bioanalysis 2011, 3:2255-2257.
31. Wishart D.S. Quantitative metabolomics using NMR. Trends Anal Chem 2008, 27:228-237.
32. Xia J., Psychogios N., Young N., Wishart D.S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 2009, 37:W652-W660. [Web Server issue].
33. Boccard J., Veuthey J.L., Rudaz S. Knowledge discovery in metabolomics: an overview of MS data handling. J Sep Sci 2010, 33:290-304.
34. van den Berg R.A., Hoefsloot H.C., Westerhuis J.A., Smilde A.K., van der Werf M.J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006, 7:142.
35. McIntire D.D., Bloom S.L., Casey B.M., Leveno K.J. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999, 340:1234-1238.
36. Brooks A.A., Johnson M.R., Steer P.J., Pawson M.E., Abdalla H.I. Birth weight: nature or nurture?. Early Hum Dev 1995, 42:29-35.
37. Forsdahl A. Points which enlighten the high mortality rate in the county of Finnmark. Can the high mortality rate today be a consequence of bad conditions of life in childhood and adolescence?. Tidsskr Nor Laegeforen 1973, 93:661-667.
38. Barker D.J., Winter P.D., Osmond C., Margetts B., Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2:577-580.
39. Barker D.J., Osmond C. Low birth weight and hypertension. BMJ 1988, 297:134-135.
40. Barker D.J. Intrauterine programming of adult disease. Mol Med Today 1995, 1:418-423.
41. Dessì A., Atzori L., Noto A., et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):35-39.
42. Nissen P.M., Nebel C., Oksbjerg N., Bertram H.C. Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes. J Biomed Biotechnol 2011, 2011:1-8.
43. Favretto D., Cosmi E., Ragazzi E., et al. Cord blood metabolomic profiling in intrauterine growth restriction. Anal Bioanal Chem 2012, 402:1109-1121.
44. Horgan R.P., Broadhurst D.I., Walsh S.K., et al. Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy. J Proteome Res 2011, 10:3660-3673.
45. Ivorra C., García-Vicent C., Chaves F.J., Monleón D., Morales J.M., Lurbe E. Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med Jul 9 2012, 10:142.
46. Hyde M.J., Beckkonert O.P., Yap I.K.S., Booms C., Gale C.R.K., Logan K., et al. The effect of preterm delivery on the urinary metabolome. Neonatal Society 2010 Summer Meeting, UK 2010, http://www.neonatalsociety.ac.uk/meetings/2010_summer_program.shtml.
47. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) Jun 1 2011, 3:1005-1012.
48. 1H-NMR-based metabolic profiling of maternal and umbilical cord blood indicates altered materno-foetal nutrient exchange in preterm infants. PLoS One 2012, 7(1):e29947.
49. Bell J.D., Brown J.C., Nicholson J.K., Sadler P.J. Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett 1987, 215:311-315.
50. Regnault T.R., Friedman J.E., Wilkening R.B., Anthony R.V., Hay W.W. Fetoplacental transport and utilization of amino acids in IUGR - a review. Placenta 2005, 26(Suppl. A):s52-s62.
51. Alexandre-Gouabau M.C., Courant F., Moyon T., et al. Maternal and cord blood LC-HRMS metabolomics reveal alterations in energy and polyamine metabolism, and oxidative stress in very-low birth weight infants. J Proteome Res 2013, 12:2764-2778.
52. Althabe F., Belizan J.F. Caesarean section: the paradox. Lancet 2006, 368:1472-1473.
53. Hashimoto F., Nishiumi S., Miyake O., et al. Metabolomics analysis of umbilical cord blood clarifies changes in saccharides associated with delivery method. Early Hum Dev 2013, 89:315-320.
54. Paladini P., Paladini A., Noto A., et al. Urinary metabolomics in twins at birth. J Pediatr Neonat Individual Med 2012, 1:113.
55. Alul F.Y., Cook D.E., Shchelochkov O.A., et al. The heritability of metabolic profiles in newborn twins. Heredity 2013, 110:253-258.
56. Shah A.A., Craig D.M., Sebek J.K., et al. Metabolic profiles predict adverse events after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2012, 143:873-878.
57. Lawn J.E., Cousens S., Zupan J. 4 million neonatal deaths: when? Where? Why?. Lancet 2005, 365:891-900.
58. de Hann M., Wyatt J.S., Roth S., Vargha-Khadem F., Gadian D., Mishki M. Brain and cognitive-behavioural development after asphyxia at term birth. Dev Sci 2006, 9:350-358.
59. Odd D.E., Lewis G., Whitelaw A., Gunnell D. Resuscitation at birth and cognition at 8years of age: a cohort study. Lancet 2009, 373:1615-1622.
60. Fellman V., Raivio K.O. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr Res 1997, 41:599-606.
61. Banupriya C., Ratnakar P., Doureradjou N., Mondal N., Vishnu B., Koner B.C. Can urinary excretion rate of malondialdehyde, uric acid and protein predict the severity and impending death in perinatal asphyxia?. Clin Biochem 2008, 41:968-973.
62. Chu C.Y., Xiao X., Zhou X.G., et al. Metabolomic and bioinformatic analyses in asphyxiated neonates. Clin Biochem 2006, 39:203-209.
63. Walsh B.H., Broadhurst D.I., Mandal R., et al. The metabolomic profile of umbilical cord blood in neonatal hypoxic ischaemic encephalopathy. PLoS One 2012, 7:e50520.
64. Solberg R., Enot D., Deigner H.P., et al. Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One 2010, 5:e9606.
65. Beckstrom A.C., Humston E.M., Snyder L.R., Synovec R.E., Juul S.E. Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model. J Chromatogr A 2011, 1218:1899-1906.
66. 31P NMR after mild hypothermia treatments of oxygen-glucose deprivation in a neonatal brain slice model of asphyxia. J Cereb Blood Flow Metab 2011, 31:547-559.
67. Atzori L., Xanthos T., Barberini L., et al. A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome. J Matern Fetal Neonatal Med 2010, 23(S3):134-137.
68. Fabiano A., Gazzolo D., Zimmermann L.J., et al. Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):55-58.
69. 1H-NMR [Nuclear Magnetic Resonance] spectroscopy of urine at birth predictive as ultrasound?. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2). [I].
70. Fanos V., Pusceddu M., Dessì A., Marcialis M.A. Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm newborns?. Clinics (Sao Paulo) 2011, 66:2141-2149.
71. Moco S., Collino S., Rezzi S., Martin F.P. Metabolomics perspectives in pediatric research. Pediatr Res 2013, 73:570-576.
72. 1H NMR metabolomics study of age profiling in children. NMR Biomed 2009, 22:826-833.
73. Carraro S., Rezzi S., Reniero F., et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007, 175:986-990.
74. Saude E.J., Skappak C.D., Regush S., et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 2011, 127:757-764.
75. Mattarucchi E., Baraldi E., Guillou C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed Chromatogr 2012, 26:89-94.
76. Carraro S., Giordano G., Piacentini G., et al. Asymmetric dimethylarginine [ADMA] in exhaled breath condensate and serum of asthmatic children. Chest Feb 14 2013, [Epub ahead of print]. 10.1378/chest.12-2379.
77. Laiakis E.C., Morris G.A., Fornace A.J., Howie S.R. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One 2010, 5. [pii:e12655].
78. Atzei A., Atzori L., Moretti C., et al. Metabolomics in paediatric respiratory diseases and bronchiolitis. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):59-62.
79. Kawashima H., Oguchi M., Ioi H., et al. Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci 2006, 116:927-936.
80. Yap I.K., Angley M., Veselkov K.A., Holmes E., Lindon J.C., Nicholson J.K. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 2010, 9:2996-3004.
81. Jacob Z., Li H., Makaryus R., et al. Metabolomic profiling of children's brains undergoing general anesthesia with sevoflurane and propofol. Anesthesiology 2012, 117:1062-1071.
82. Serci C., Murgia F., Pruna P., et al. A non-invasive approach to characterize epileptic children born ELBW compared to non epileptic: a metabolomic point of view. J Pediatr Neonat Individual Med 2012, 1:118.
83. Harambat J., van Stralen K.J., Kim J.J., Tizard E.J. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012, 27:363-373.
84. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2008 Annual report 2008, The EMMES Corporation, Rockville, MD.
85. Ardissino G., Daccò V., Testa S., et al. ItalKid project epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 2003, 111:e382-e387.
86. Staples A.O., Greenbaum L.A., Smith J.M., et al. Association between clinical risk factors and progression of chronic kidney disease in children. Clin J Am Soc Nephrol 2010, 5:2172-2179.
87. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012, 2:1-138.
88. Zhao Y.Y. Metabolomics in chronic kidney disease. Clin Chim Acta 2013, 422:59-69.
89. Fanos V., Fanni C., Ottonello G., Noto A., Dessì A., Mussap M. Metabolomics in adult and pediatric nephrology. Molecules 2013, 18:4844-4857.
90. Beger R.D., Holland R.D., Sun J., et al. Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr Nephrol 2008, 23:977-984.
91. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci (Elite Ed) 2010, 2:725-732.
92. Friedrich N. Metabolomics in diabetes research. J Endocrinol 2012, 215:29-42.
93. Wang-Sattler R., Yu Z., Herder C., et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012, 8:615. 10.1038/msb.2012.43.
94. Orešič M., Simell S., Sysi-Aho M., et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 2008, 205:2975-2984.
95. Sysi-Aho M., Ermolov A., Gopalacharyulu P.V., et al. Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol 2011, 7:e1002257.
96. Sellitto M., Bai G., Serena G., et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One 2012, 7:e33387.
97. Wolak J.E., Esther C.R., O'Connell T.M. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers 2009, 14:55-60.
98. Robroeks C.M., van Berkel J.J., Dallinga J.W., et al. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res 2010, 68:75-80.
99. Wahl S., Yu Z., Kleber M., et al. Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts 2012, 5:660-670.
100. Mihalik S.J., Michaliszyn S.F., de las Heras J., et al. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care 2012, 35:605-611.
101. Baumgartner C., Baumgartner D. Biomarker discovery, disease classification, and similarity query processing on high-throughput MS/MS data of inborn errors of metabolism. J Biomol Screen 2006, 11:90-99.
102. Want E.J., Cravatt B.F., Siuzdak G. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 2005, 6:1941-1951.
103. Wikoff W.R., Gangoiti J.A., Barshop B.A., Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 2007, 53:2169-2176.
104. Reinecke C.J., Koekemoer G., van der Westhuizen F.H., et al. Metabolomics of urinary organic acids in respiratory chain deficiencies in children. Metabolomics 2012, 8:264-283.
105. Vangala S., Tonelli A. Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity?. AAPS J 2007, 9:E284-E297.
106. German J.B., Bauman D.E., Burrin D.G., et al. Metabolomics in the opening decade of the 21st century: building the roads to individualized health. J Nutr 2004, 134:2729-2732.
107. Zeisel S.H., Freake H.C., Bauman D.E., et al. The nutritional phenotype in the age of metabolomics. J Nutr 2005, 135:1613-1616.
108. Bertram H.C., Hoppe C., Petersen B.O., Duus J.Ø., Mølgaard C., Michaelsen K.F. An NMR-based metabonomic investigation on effects of milk and meat protein diets given to 8-year-old boys. Br J Nutr 2007, 97:758-763.
109. Marincola F.C., Reali A., Barberini L., et al. NMR metabolic target analysis of the aqueous human breast extract. J Matern Fetal Neonatal Med 2011, 25(Suppl. 5):62-67.
110. Poroyko V., Morowitz M., Bell T., et al. Diet creates metabolic niches in the "immature gut" that shape microbial communities. Nutr Hosp 2011, 26:1283-1295.
111. Lonnerdal B. Preclinical assessment of infant formula. Ann Nutr Metab 2012, 60:196-199.
112. Johnson C.H., Patterson A.D., Idle J.R., Gonzalez F.J. Xenobiotic metabolomics: major impact on the metabolome. Annu Rev Pharmacol Toxicol 2012, 52:37-56.
113. Clayton T.A., Lindon J.C., Cloarec O., et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006, 440:1073-1077.
114. Fanos V., Barberini L., Antonucci R., Atzori L. Pharma-metabolomics in neonatology: is it a dream or a fact?. Curr Pharm Des 2012, 18:2996-3006.
115. Carraro S., Giordano G., Reniero F., Perilongo G., Baraldi E. Metabolomics: a new frontier for research in pediatrics. J Pediatr 2009, 154:638-644.
116. MSI Board Members, Sansone S.A., Fan T., et al. The metabolomics standards initiative (MSI). Nat Biotechnol 2007, 25:846-848.